National Science Foundation

Auxilium Health is creating low-cost, smart biomaterials for difficult-to-heal wounds.

Dynocardia, Inc. is a biomedical device company focused on developing innovative healthcare solutions. Founded in 2018 and based in Cambridge, Massachusetts, Dynocardia specializes in manufacturing wireless blood pressure measurement equipment. Its flagship product, the ViTrack, is a wrist-wearable device that provides users with accurate, real-time measurements of blood pressure, heart rate, heart rhythm, and respiration rate. The technology employs a non-invasive optomechanical sensor to deliver continuous and precise blood pressure readings, comparable to traditional intra-arterial methods. By addressing critical unmet needs in health monitoring, Dynocardia aims to enhance patient care and facilitate easier access to vital health metrics.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

LiteraSeed is a digital health company that has created a clinically validated platform aimed at enhancing communication between patients and healthcare providers. This platform is specifically designed to assist low health literate patient populations, which includes individuals who may face language barriers or have difficulty articulating their health concerns. By facilitating accurate and remote self-reporting of symptoms, LiteraSeed's technology seeks to prevent misdiagnoses, adverse health events, and unnecessary emergency room visits. The company's focus on improving access to care is particularly beneficial for public health providers serving diverse communities, ensuring that disadvantaged patients receive the attention and resources they need for effective healthcare management.

CenSyn is a healthcare company focused on advancing brain health screening through innovative technology. The company develops a handheld EEG monitoring device that facilitates the expedited screening of conditions such as Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software allows for long-term brain health management, capturing brain electrical activity in real-time and enabling clinicians to access EEG data wirelessly from any location. This technological approach not only aids in the rapid diagnosis of various brain health issues but also supports immediate treatment, ultimately aiming to reduce inpatient costs. By making brain health screening more accessible, CenSyn seeks to improve outcomes for diverse patient populations.

Alerje, Inc. is a Detroit-based company focused on enhancing the quality of life for individuals with food allergies. Founded in 2015, Alerje has developed an innovative emergency medicine and digital oral immunotherapy management platform. Central to its offerings is an epinephrine auto-injector that conveniently fits into a smartphone case, promoting better adherence and alert management for users. The company also provides a mobile application that allows users to create personalized food allergy profiles, share these profiles with caregivers and medical professionals, and filter recipes based on allergen information. Additionally, the app includes features for scanning grocery items to identify potential allergens, thus aiding families and healthcare providers in making informed dietary choices. Alerje's platform is validated by the National Science Foundation and aims to improve emergency response and overall management of food allergies.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

ProMedix is a medical device startup based in Portland, Oregon, founded in 2019. The company specializes in the development of noninvasive, fingertip patient monitors aimed at enhancing the recognition of circulatory dysfunction. Its innovative devices are designed to assist in the diagnostic evaluation and monitoring of various medical conditions, such as trauma, dehydration, and sepsis. By facilitating effective home patient monitoring, ProMedix aims to simplify both home and critical care, helping physicians to prevent unnecessary acute visits and improve overall emergency and critical care outcomes.

Moshion is a technology company specializing in healthcare workflow optimization, specifically targeting the nursing shortage. It employs 3D image sensors, preserving patient privacy, to gather movement data, which is then analyzed using machine learning models. Moshion's primary focus is to prevent pressure injuries in bedridden patients by monitoring and optimizing patient turning protocols. The platform tracks adherence to these protocols, provides personalized turn schedules, sends reminders to nurses, and automates documentation. This data-driven approach aims to enhance patient care, improve nursing efficiency, and reduce the risk of life-threatening events.

Claria Medical is a pre-commercial medical device start-up focused on addressing unmet needs in women's healthcare, particularly in gynecologic surgery. The company specializes in the development of minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has achieved early recognition for its innovative approach, receiving a "Safer Technologies Designation" from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private financing, as well as prestigious grants from the National Science Foundation and the National Institutes of Health, to support the advancement of its medical devices aimed at improving surgical outcomes for women.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

HairDays is an AI-powered health data company that has developed a unique hair intelligence platform aimed at simplifying hair classification, care, and product selection. This innovative platform provides personalized recommendations for maintaining healthy hair by curating relevant content and facilitating the discovery and purchase of hair care products. Users can track their hair growth progress and improve their hair conditions through tailored insights, making HairDays a valuable resource for individuals seeking to enhance their hair care routines.

Lura Health is a pioneering company that has developed a non-invasive continuous health monitoring platform utilizing saliva as a diagnostic fluid. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company focuses on chronic disease management, targeting conditions such as heart disease, chronic kidney disease, diabetes, and tooth decay. Lura Health's innovative sensors are designed to be integrated into patient-friendly orthodontic devices, including removable retainers and fixed brackets. These sensors continuously monitor oral acidity and other analytes in saliva, automatically transmitting valuable health data to a mobile application. This approach empowers users to track key diagnostic metrics within their oral environment, facilitating improved personal health management and potentially enhancing clinical outcomes.

Our mission is to promote innovation that empowers people to have the knowledge and tools to solve everyday medical problems in any setting. We do this by providing a doctor’s approach to stopping nosebleeds at your fingertips. Bleed Freeze allows people to confidently take control and treat nosebleeds anywhere.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Dynocardia, Inc. is a biomedical device company focused on developing innovative healthcare solutions. Founded in 2018 and based in Cambridge, Massachusetts, Dynocardia specializes in manufacturing wireless blood pressure measurement equipment. Its flagship product, the ViTrack, is a wrist-wearable device that provides users with accurate, real-time measurements of blood pressure, heart rate, heart rhythm, and respiration rate. The technology employs a non-invasive optomechanical sensor to deliver continuous and precise blood pressure readings, comparable to traditional intra-arterial methods. By addressing critical unmet needs in health monitoring, Dynocardia aims to enhance patient care and facilitate easier access to vital health metrics.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

Liv Labs is a consumer health technology company focused on improving pelvic floor fitness. The company develops solutions that are both convenient and affordable for users. Their primary product is a pelvic floor fitness kit designed to help women manage urine leakage during physical activities. This kit aims to enable users to regain control over urinary incontinence, thereby enhancing their quality of life.

CereVu Medical specializes in developing advanced medical devices. Their primary product is a wearable, single-use forehead patch connected to a reusable console, designed to monitor and analyze cerebral hemodynamics in real-time. This system employs proprietary algorithms to provide continuous pain score assessments, enabling healthcare professionals to tailor treatments based on individual patient needs.

QuadraLynx is a company focused on developing wearable biometric devices aimed at enhancing speech and voice for adults with motor speech disorders. Particularly, their technology targets individuals experiencing volume control issues, a common challenge associated with Parkinson's disease and similar neurological conditions. The wearable, battery-operated device provides users with real-time feedback by vibrating when their voice reaches a pathological state, thereby assisting in improving communication and overall quality of life for those affected by these disorders. Through its innovative approach, QuadraLynx seeks to make a meaningful impact on the daily lives of its users.

EchoWear is a company focused on enhancing healthcare access through its innovative smartwatch-based system. This system facilitates meaningful interactions between patients and care teams, promoting the development of actionable digital health services. By prioritizing age-friendly health technologies, EchoWear aims to improve the overall healthcare experience for users, ensuring that they can effectively engage with their health management through digital solutions.

Pragma Health provides digital healthcare services. They permit users to perform different tests for cardiovascular, hematology, infectious diseases, and others in the privacy of their home and provide accurate, immediate results, enabling them to get a convenient, cost-effective, and accurate healthcare testing process.

Empo Health is a company focused on in-home health monitoring, specifically designed to enhance patient care and outcomes. It has developed an innovative bathroom scale and digital health platform that allows for the early detection of diabetic foot conditions, thereby helping to prevent amputations. The products offered by Empo Health include bathroom scales and full-color imaging scales that provide reliable visual data to both patients and clinicians, facilitating better monitoring outside the clinical setting. This integration into patients' daily lives aims to improve the standard of care for individuals at risk of diabetes-related complications.

KovaDx is a healthcare company focused on improving the lives of individuals suffering from Sickle Cell Disease and other hemolytic anemias. It has developed an affordable point-of-care diagnostic and monitoring tool that leverages Quantitative Phase Imaging and deep learning technology. This innovative system aims to bridge gaps in care for blood diseases by enhancing the understanding of blood health, supporting care management, and predicting outcomes to prevent severe complications. By providing accessible and effective monitoring solutions, KovaDx strives to improve the therapeutic pipeline for rare blood diseases and ultimately enhance the overall prognosis and quality of life for affected patients.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Innsightful is a developer of wearable devices focused on monitoring and detecting symptoms of anxiety and stress, specifically targeting the student population. The company's integrated digital health solution combines artificial intelligence and machine learning with biometric data to facilitate automated, early detection of heightened stress levels. Through its wearable app, Innsightful not only enables users to gain a deeper understanding of their mental health but also provides access to therapists for personalized recommendations and progress reviews. This innovative approach aims to revolutionize the management of mental health issues, offering individuals tools to alleviate their symptoms effectively.

LiteraSeed is a digital health company that has created a clinically validated platform aimed at enhancing communication between patients and healthcare providers. This platform is specifically designed to assist low health literate patient populations, which includes individuals who may face language barriers or have difficulty articulating their health concerns. By facilitating accurate and remote self-reporting of symptoms, LiteraSeed's technology seeks to prevent misdiagnoses, adverse health events, and unnecessary emergency room visits. The company's focus on improving access to care is particularly beneficial for public health providers serving diverse communities, ensuring that disadvantaged patients receive the attention and resources they need for effective healthcare management.

Alerje, Inc. is a Detroit-based company focused on enhancing the quality of life for individuals with food allergies. Founded in 2015, Alerje has developed an innovative emergency medicine and digital oral immunotherapy management platform. Central to its offerings is an epinephrine auto-injector that conveniently fits into a smartphone case, promoting better adherence and alert management for users. The company also provides a mobile application that allows users to create personalized food allergy profiles, share these profiles with caregivers and medical professionals, and filter recipes based on allergen information. Additionally, the app includes features for scanning grocery items to identify potential allergens, thus aiding families and healthcare providers in making informed dietary choices. Alerje's platform is validated by the National Science Foundation and aims to improve emergency response and overall management of food allergies.

Notus Labs develops wearable devices that enable remote and non-invasive monitoring of health and performance. Their technology provides users, including both individuals and healthcare professionals, with a comprehensive and continuous overview of vital signs. This information is crucial for optimizing triaging in situations of sudden physiological deterioration. The devices aim to reduce the risk of overexertion injuries and heat-related illnesses, facilitating safer physical activity. Additionally, the products offer training suggestions to help users maximize their physical performance growth while ensuring their well-being.

Alva Health is a company specializing in the development of healthcare wearables designed for remote stroke monitoring. Its patented devices operate continuously to detect stroke signatures, specifically targeting the early detection of hemiparesis, which is paralysis affecting one side of the body. These wearables are aimed at older individuals at high risk of stroke, enabling them to prevent disability and maintain independence while providing reassurance to their families. By connecting users with emergency services, Alva Health seeks to transform stroke treatment and advance the creation and validation of innovative neurotechnologies.

Midday is an app that leverages AI, sensor technology, and digital therapeutics to support women on their menopause journey using personalized insights that illuminate what is happening physically and emotionally during menopause, providing the right intervention at the right time to manage menopause symptoms and promote healthy aging.

Immersive Reality Group, founded in 2004 and headquartered in Bozeman, Montana, specializes in artificial intelligence and virtual reality technology to deliver personalized healthcare solutions. The company operates a platform designed for stress and anxiety management, which utilizes predictive analytics for health monitoring in home environments. By offering tailored virtual reality experiences, Immersive Reality Group aims to help users alleviate symptoms of stress and anxiety in real time, while also providing educational tools to teach effective coping strategies.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Grapevine Health is a data-driven health media company focused on delivering health information to underserved communities. By utilizing technical expertise and trusted messengers, the company aims to democratize health information and empower patients through empathetic storytelling. Grapevine Health also offers health literacy services that assist health systems, insurers, and medical providers in enhancing community outreach and engagement. Their strategies include designing and delivering culturally appropriate communications and marketing materials, enabling clients to provide health information that is relatable and easily understandable. Through these efforts, Grapevine Health seeks to promote health literacy and sustain healthy behaviors within the communities it serves.

Seaspire Skincare specializes in the development of multifunctional colorants and active ingredients, drawing inspiration from the ocean's biodiversity. The company focuses on addressing chronic and cosmetic skin and hair conditions while aiming to replace harmful components commonly found in sunscreens. A key innovation is the biomolecule Xanthochrome, which provides protection against a wider spectrum of ultraviolet radiation compared to existing UV filters. This product not only supports preventative skincare but also promotes sustainability within the skincare industry by minimizing harmful effects on both human health and marine ecosystems. Seaspire Skincare is committed to delivering safer, less toxic alternatives for consumers and the environment.

Amissa develops mobile and wearable application solutions aimed at alleviating the challenges of Alzheimer's care. The company’s technology empowers caregivers by allowing them to geo-fence and locate loved ones who may wander, remotely monitor their activity and health, and predict behaviors associated with Alzheimer's. In addition to these features, Amissa offers wearable biosensors integrated with a cloud-based data platform that collects biometric data on activity levels, sleep patterns, and physiological changes. This comprehensive approach not only aids caregivers in monitoring patients but also provides valuable insights for researchers seeking to understand disease progression, ultimately enhancing the quality of life for individuals with dementia and related disorders.

Quick-Med Technologies, Inc. is a life sciences company dedicated to developing and commercializing proprietary technologies aimed at infection prevention and control within the medical and consumer healthcare sectors. Founded in 1997 and headquartered in Gainesville, Florida, the company specializes in the research and development of biomedical products and devices with antibacterial applications. Its core technologies include NIMBUS, a family of advanced polymers with antimicrobial and hemostatic properties; Stay Fresh, a chemical formulation for textiles that provides durable antimicrobial protection; and MultiStat, a series of patented methods and compounds for skin therapy. Quick-Med serves a variety of clients, including government agencies and companies in healthcare, medical, apparel, textile, and personal care industries.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

Active Therapy Systems, founded in 2017 and based in Nicholasville, Kentucky, specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The company's innovative platform emphasizes personalized therapies and exercise, facilitating remote patient monitoring to enhance the management of symptoms associated with Parkinson's disease. By allowing patients to engage in therapeutic activities from the comfort of their own homes, Active Therapy Systems aims to improve quality of life and promote greater participation in daily activities for those affected by this condition.

Kepler Diagnostics is a healthcare technology company focused on improving research, health, and wellness through its innovative specimen collection devices. The company's offerings stabilize sensitive tests and facilitate the remote collection of various bodily fluids, such as urine, serum, and plasma. By allowing for simple transportation at ambient temperature, Kepler Diagnostics enhances accessibility to accurate and cost-effective diagnostic tools for individuals in the community.

Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.

Fathhome is a company based in Oakland, California, founded in 2015, that specializes in the development of a sanitizing device designed for the dry sanitization of household items. The device utilizes air pressure and ionization technology to effectively sanitize a variety of products, including packages, deliveries, clothing, shoes, helmets, personal protective equipment, and electronic devices like phones and computers. By eliminating the need for water, detergents, or chemicals, Fathhome's innovative approach enables users to remove harmful viruses and bacteria from their belongings, providing a convenient and effective solution for maintaining hygiene in everyday life.

Progenitor MDX is a biotechnology company focused on developing advanced cellular immunotherapy technologies and innovative solutions for managing COVID-19 infections. The company offers a comprehensive approach that includes testing and actionable infection management plans, aimed at providing reassurance to communities. In addition to its COVID-19 management solutions, Progenitor MDX specializes in cellular reprogramming, utilizing a streamlined method that incorporates all Yamanaka factors into a single vector. This technology enables the creation of allogeneic off-the-shelf CAR constructs from various cell sources, facilitating the efficient insertion of multiple genetic elements. By enhancing the industrial workflows for producing engineered cell therapies, Progenitor MDX plays a critical role in advancing immune-oncology and the development of new therapeutic options.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.

Claria Medical is a pre-commercial medical device start-up focused on addressing unmet needs in women's healthcare, particularly in gynecologic surgery. The company specializes in the development of minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has achieved early recognition for its innovative approach, receiving a "Safer Technologies Designation" from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private financing, as well as prestigious grants from the National Science Foundation and the National Institutes of Health, to support the advancement of its medical devices aimed at improving surgical outcomes for women.

Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

HabitAware, Inc. is a Minneapolis-based company that develops wearable devices aimed at helping individuals manage compulsive behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. The company's flagship product, Liv, is a smart awareness bracelet that utilizes motion sensors to detect these subconscious actions. It connects to a mobile application that provides users with training to recognize and track their behaviors, identify triggers, and implement healthier coping strategies. Founded in 2014, HabitAware combines technology with behavioral science to empower users, particularly those affected by trichotillomania, to gain awareness and control over their habits. The products are available for purchase online.

Intake Health is a company focused on continuous passive health monitoring through innovative technology. Its primary product is a device that hangs on a toilet, automatically testing urine from flush water to provide lab-quality results for various health and diet indicators. This device does not require any behavior changes from users, making it easy to integrate into daily life. By utilizing advanced biosensors and wireless technology, the device quantifies specific urinary biomarkers to accurately track hydration and nutrition, delivering instant insights directly to users' smartphones. The company believes that leveraging artificial intelligence alongside thousands of personalized biomarkers collected over time will enhance the prediction of health conditions and support personalized preventive care as its user base expands. Intake Health has received funding from notable organizations such as the National Science Foundation and the National Institutes of Health.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

Lura Health is a pioneering company that has developed a non-invasive continuous health monitoring platform utilizing saliva as a diagnostic fluid. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company focuses on chronic disease management, targeting conditions such as heart disease, chronic kidney disease, diabetes, and tooth decay. Lura Health's innovative sensors are designed to be integrated into patient-friendly orthodontic devices, including removable retainers and fixed brackets. These sensors continuously monitor oral acidity and other analytes in saliva, automatically transmitting valuable health data to a mobile application. This approach empowers users to track key diagnostic metrics within their oral environment, facilitating improved personal health management and potentially enhancing clinical outcomes.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

CereVu Medical specializes in developing advanced medical devices. Their primary product is a wearable, single-use forehead patch connected to a reusable console, designed to monitor and analyze cerebral hemodynamics in real-time. This system employs proprietary algorithms to provide continuous pain score assessments, enabling healthcare professionals to tailor treatments based on individual patient needs.

Telling.ai is a telehealth platform that focuses on respiratory monitoring and lung health assessment. The company analyzes voice and breath sounds to identify indicators of various medical conditions, particularly respiratory diseases and infections. Telling.ai's platform is designed to assist individuals with chronic lung conditions, enabling them to manage their health more effectively and prevent acute exacerbations. By capturing respiratory sounds in real-world settings, the platform provides real-time feedback while optimizing data quality through advanced denoising techniques. This allows for timely interventions that help avoid costly hospitalizations, ultimately benefiting the over 1 billion people affected by acute or chronic respiratory disorders.

Ikona Health is a company focused on enhancing healthcare education and training through innovative technology. The firm develops a medical learning platform that integrates immersive content with storytelling to facilitate patient education and equip healthcare providers, particularly senior caregivers, with the knowledge needed to address kidney diseases. By leveraging virtual reality applications and interactive modules, Ikona Health generates unique and immersive data sets that yield real-time actionable insights for healthcare providers and care teams. This approach aims to bridge the gap in healthcare education, ultimately improving patient understanding and treatment outcomes.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Hera Global Tech specializes in developing innovative personal safety solutions. Their flagship product is a wearable device and accompanying smartphone app, designed to ensure women's safety. The device intuitively detects high-risk situations based on physiological and personal responses, then alerts the wearer's pre-selected contacts or community, along with their location. The company aims to empower individuals and foster a sense of security by providing accessible, user-driven technology.

HumanGo Training is an imagined solution that understands an athlete’s life beyond their training that knows how many last-minute, unexpected work, family, and friends things can come up in a week.

Manus Robotics is a developer of advanced health and wellness devices aimed at promoting independent and healthy living. The company specializes in a wearable robot that offers intelligent daily living assistance to individuals with disabilities. In addition to facilitating daily activities, this device collects and analyzes muscle data from patients, which is crucial for rehabilitation. By focusing on these innovative solutions, Manus Robotics helps individuals with disabilities improve their quality of life and regain their independence.

Oncodisc, Inc., based in Walnut Creek, California, is a medical technology company that specializes in manufacturing connected vascular access devices. These devices are embedded with advanced sensors and communication technology, designed to facilitate oncology drug delivery while monitoring the health of patients undergoing high-risk outpatient therapy. The company's product line includes an implantable vascular access port and data analytics solutions that provide status alerts for early signs of complications, enabling timely interventions and reducing hospitalizations. Additionally, Oncodisc offers a Remote Care Platform with mobile tools for patient-reported outcomes, telehealth services, and patient engagement. Incorporated in 2018, the company aims to enhance cancer care through integrated medical devices, remote monitoring, and data analytics.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Chosen Diagnostics is a developer of innovative biomarker diagnostic kits designed to enhance healthcare delivery for neonates. The company's primary focus is on diagnosing a prevalent and life-threatening bowel disease in preterm infants. Its diagnostic kit provides more accurate results compared to existing options, facilitating earlier medical intervention. By enabling healthcare professionals to detect critical conditions sooner, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately contributing to better health and survival rates in this vulnerable population.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, specializes in the development and manufacturing of innovative medical devices and bioanalytical chemistry solutions aimed at managing chronic inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure. The company’s core product, the BioSense Airway Monitoring Device, enables patients to monitor airway inflammation through non-invasive analysis of biomarkers in exhaled breath condensate, allowing for reliable at-home assessments without complex breathing maneuvers. This device, paired with a mobile application, helps patients track symptoms, evaluate medication efficacy, and share data with healthcare providers. BioLum Sciences also offers a blood analysis device that utilizes a simple finger-prick test to measure nitric oxide and related metabolites, providing critical insights into endothelial function and cardiovascular health. With a focus on remote patient monitoring and personalized treatment plans, BioLum Sciences aims to enhance patient outcomes and streamline healthcare costs through innovative biomarker analysis.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It develops tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance the capacity, satisfaction, outcomes, and revenue for healthcare providers. Viora Health's offerings are designed to improve adherence to diabetes prevention and support patients through online tools that track data and report progress to diabetes prevention programs, facilitating compliance with insurance requirements. Funded by reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, Viora Health's initiatives have shown significant success, achieving a 75% satisfaction score and double retention rates, while also leading to improved patient outcomes such as reduced stress, increased social support, and better access to food.

Prenovo is a healthcare services provider that specializes in personalized care. It combines clinical research, proven medical applications, and technology to engage and empower patients, as well as their care teams, throughout the surgical journey, from consultation to recovery. The company's platform focuses on patient engagement in activities like exercise, breathing, and nutrition to enhance surgical outcomes.

HabitAware, Inc. is a Minneapolis-based company that develops wearable devices aimed at helping individuals manage compulsive behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. The company's flagship product, Liv, is a smart awareness bracelet that utilizes motion sensors to detect these subconscious actions. It connects to a mobile application that provides users with training to recognize and track their behaviors, identify triggers, and implement healthier coping strategies. Founded in 2014, HabitAware combines technology with behavioral science to empower users, particularly those affected by trichotillomania, to gain awareness and control over their habits. The products are available for purchase online.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, founded in 2017. It specializes in manufacturing handheld spirometers that allow asthmatic patients to monitor their lung health and medication usage. The company also develops software that connects patients with chronic respiratory diseases to their healthcare providers, enhancing communication and care. VitalFlo's remote monitoring system tracks lung function and air quality, identifying potential triggers for asthma attacks. By analyzing this data, the company delivers actionable insights to clinical teams, enabling them to offer timely recommendations and improve patient management. This innovative approach aims to keep asthma patients out of emergency rooms and redefine the standard of care in asthma management.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.

Alva Health is a company specializing in the development of healthcare wearables designed for remote stroke monitoring. Its patented devices operate continuously to detect stroke signatures, specifically targeting the early detection of hemiparesis, which is paralysis affecting one side of the body. These wearables are aimed at older individuals at high risk of stroke, enabling them to prevent disability and maintain independence while providing reassurance to their families. By connecting users with emergency services, Alva Health seeks to transform stroke treatment and advance the creation and validation of innovative neurotechnologies.

HeroWear is a company focused on developing innovative wearable technology aimed at reducing physical strain and fatigue for workers in demanding jobs. Its flagship product, the Apex, is a back-assist exosuit designed for both men and women, providing support while maintaining a comfortable fit akin to regular clothing. This exosuit incorporates patent-pending dual-mode technology, allowing users to easily toggle the back assistance on or off, making it adaptable for various work environments. Additionally, its modular textile design offers over 50 possible combinations, ensuring that the fit and level of support can be customized to meet the unique needs of each user. By specializing in lift assistance, HeroWear's products contribute to improved safety, health, and productivity for those engaged in physically strenuous tasks.

Intake Health is a company focused on continuous passive health monitoring through innovative technology. Its primary product is a device that hangs on a toilet, automatically testing urine from flush water to provide lab-quality results for various health and diet indicators. This device does not require any behavior changes from users, making it easy to integrate into daily life. By utilizing advanced biosensors and wireless technology, the device quantifies specific urinary biomarkers to accurately track hydration and nutrition, delivering instant insights directly to users' smartphones. The company believes that leveraging artificial intelligence alongside thousands of personalized biomarkers collected over time will enhance the prediction of health conditions and support personalized preventive care as its user base expands. Intake Health has received funding from notable organizations such as the National Science Foundation and the National Institutes of Health.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

ImpeDx Diagnostics Inc. is a medical device company founded in 2013 and based in Leawood, Kansas. The company specializes in the development and marketing of an innovative system designed for the rapid detection of bacteria in blood culture specimens, specifically for clinical laboratories. ImpeDx's mission focuses on reducing the mortality rate among septic patients by enabling quicker diagnostic results, which allows healthcare professionals to initiate targeted therapeutic treatments sooner. Their technology significantly shortens the time required for blood culture results from days to hours, thereby improving patient outcomes and contributing to substantial healthcare savings.

Tanzen Medical is a company based in Severna Park, Maryland, founded in 2017. It specializes in the development of clinically accurate wearable devices designed to assess and improve sleep quality in a home setting. The company's innovative device aids in diagnosing sleep-related disorders, such as ADHD and narcolepsy, by detecting nightly leg movements and enabling users to track various aspects of their sleep, including quality, position, and arousal. Tanzen Medical's focus on enhancing sleep health positions it as a key player in the wearable health technology sector.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

Taza Aya, headquartered in Ann Arbor, Michigan, is a technology company specializing in non-thermal plasma solutions. It develops and deploys innovative, non-thermal plasma technologies to neutralize airborne pathogens, enhancing air quality and safety in various industries. The company's primary focus is on creating a wearable device that integrates into building-scale HVAC systems, aiming to improve respiratory protection and comfort in workplaces and public spaces.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Active Therapy Systems, founded in 2017 and based in Nicholasville, Kentucky, specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The company's innovative platform emphasizes personalized therapies and exercise, facilitating remote patient monitoring to enhance the management of symptoms associated with Parkinson's disease. By allowing patients to engage in therapeutic activities from the comfort of their own homes, Active Therapy Systems aims to improve quality of life and promote greater participation in daily activities for those affected by this condition.

Plasmonic Diagnostics is a biotechnology company focused on developing innovative diagnostic systems for infectious diseases, sexually transmitted diseases, and cancer. The company utilizes advanced single molecule detection technology to create non-invasive and ultra-sensitive devices that target specific biomarkers. By leveraging 3D-printed components and smartphone camera technology as detectors, Plasmonic Diagnostics enhances the diagnostic process with features such as rapid time-to-detection, intrinsic signal amplification, high signal-to-noise ratios, and directional emission. This approach allows for the provision of affordable diagnostic tests, making healthcare more accessible for patients.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, founded in 2017. It specializes in manufacturing handheld spirometers that allow asthmatic patients to monitor their lung health and medication usage. The company also develops software that connects patients with chronic respiratory diseases to their healthcare providers, enhancing communication and care. VitalFlo's remote monitoring system tracks lung function and air quality, identifying potential triggers for asthma attacks. By analyzing this data, the company delivers actionable insights to clinical teams, enabling them to offer timely recommendations and improve patient management. This innovative approach aims to keep asthma patients out of emergency rooms and redefine the standard of care in asthma management.

SageSurfer operates a mental healthcare platform designed to empower individuals in overcoming behavioral health challenges by fostering collaboration among their caregivers. The platform facilitates comprehensive, coordinated, and outcome-driven personalized care for mental health and addiction treatment. It enables consumers to actively participate in their care planning, ensuring they have a stronger voice in their treatment process. By centering the consumer in the recovery plan and providing access to their entire care team, SageSurfer aims to create a supportive healthcare environment where individuals are not alone in their journey towards recovery and can easily access help when needed.

Aluna is a healthcare company based in San Francisco, California, founded in 2013, that specializes in developing a portable spirometry device aimed at improving the management of asthma. The company's innovative solution combines a spirometer with an interactive mobile application, allowing patients to monitor their asthma symptoms effectively. Through daily measurements and the use of machine learning, Aluna empowers patients and their parents to understand their respiratory conditions better and take control of their lung health. The platform provides real-time data that can be shared with healthcare providers, enabling early detection of asthma attacks and informed decision-making regarding personalized treatment plans. Aluna aims to enhance the quality of life for individuals with chronic respiratory conditions through its advanced technology and data-driven insights.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

ImpeDx Diagnostics Inc. is a medical device company founded in 2013 and based in Leawood, Kansas. The company specializes in the development and marketing of an innovative system designed for the rapid detection of bacteria in blood culture specimens, specifically for clinical laboratories. ImpeDx's mission focuses on reducing the mortality rate among septic patients by enabling quicker diagnostic results, which allows healthcare professionals to initiate targeted therapeutic treatments sooner. Their technology significantly shortens the time required for blood culture results from days to hours, thereby improving patient outcomes and contributing to substantial healthcare savings.

Aipiphany is a healthcare technology company that focuses on enhancing patient education and engagement through its innovative AI-driven solutions. The company's flagship product, Aipiphany Notes, transforms traditional electronic health record (EHR) notes into interactive tools that facilitate communication between physicians, staff, and patients. By leveraging machine learning algorithms, Aipiphany personalizes the delivery of medical content based on patients' beliefs and perceptions, enabling them to better understand complex medical information. This collaborative approach not only empowers patients to take an active role in their healthcare but also aims to improve medication adherence, enhance overall care, and reduce hospital readmission rates. Aipiphany strives to democratize access to medical knowledge, ultimately fostering a more connected and informed healthcare environment.

Elidah, Inc. is a medical device company based in Monroe, Connecticut, founded in 2015. It focuses on developing non-invasive solutions for urinary incontinence, specifically targeting women's health. The company's flagship product, Elitone, is designed to stimulate and strengthen pelvic floor muscles, helping to address both stress and urge incontinence. This device features an external electrode that is worn in the perineal region, delivering microcurrents to stimulate the nerves and tone the pelvic floor, thereby providing women with greater control over their bladder function. By offering a convenient and effective treatment option, Elidah aims to empower women to regain confidence and lead active lives without the fear of leakage.

Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device is designed for ambulatory use, allowing for impactful cardiovascular diagnostic measurements. By offering a more accurate, comfortable, and convenient alternative to traditional blood pressure monitoring methods, Bold Diagnostics aims to enhance the experience for both patients and healthcare providers.

Aluna is a healthcare company based in San Francisco, California, founded in 2013, that specializes in developing a portable spirometry device aimed at improving the management of asthma. The company's innovative solution combines a spirometer with an interactive mobile application, allowing patients to monitor their asthma symptoms effectively. Through daily measurements and the use of machine learning, Aluna empowers patients and their parents to understand their respiratory conditions better and take control of their lung health. The platform provides real-time data that can be shared with healthcare providers, enabling early detection of asthma attacks and informed decision-making regarding personalized treatment plans. Aluna aims to enhance the quality of life for individuals with chronic respiratory conditions through its advanced technology and data-driven insights.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

VoluMetrix is a company focused on creating advanced non-invasive monitoring technologies aimed at improving individual well-being. It specializes in developing innovative sensors that capture the venous waveform, providing critical insights into various physiological conditions. This technology enables healthcare practitioners to effectively monitor and assess patient health, particularly regarding congestion, in diverse settings such as homes, clinics, and hospitals. By collaborating closely with patients and healthcare providers, VoluMetrix seeks to optimize the implementation and use of its monitoring solutions, ultimately enhancing health outcomes.

WiseWear is an innovative Internet of Things (IoT) company that specializes in designing and developing connected devices aimed at enhancing health, safety, and security for families. The company focuses on integrating advanced biosensing and wireless communication technologies into everyday items, making technology unobtrusive. WiseWear's product offerings include connected sensing devices that empower users to manage their health and wellness proactively. These devices monitor human activities, provide notifications to emergency contacts during critical situations, and deliver mobile alerts for important communications. By combining style and technology, WiseWear creates products that not only serve practical purposes but also fit seamlessly into daily life.

Sanguina is a medical device and wellness tool company that specializes in innovative point-of-care diagnostics. It is currently focused on launching its first product, AnemoCheck Mobile, which is a groundbreaking smartphone application designed for the non-invasive tracking of hemoglobin levels. This app eliminates the need for painful blood draws by utilizing a color-based testing method, primarily aimed at screening for anemia. Sanguina's technology enables users to easily and effectively monitor their hemoglobin levels, enhancing accessibility to important health information.